NCT01594086

Brief Summary

Green tea contains catechins and theanine as major ingredients and has been reported to have various beneficial influences on human health. It is reported that the drinking green tea is inversely associated with serum homocysteine level in elderly. However the effect of green tea consumption on cognitive dysfunction is not clinically clarified. The purpose of this study is to investigate the effects of green tea consumption on homocysteine metabolism and cognitive dysfunction in elderly with impaired cognitive function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2012

Completed
Same day until next milestone

Study Start

First participant enrolled

May 1, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 8, 2012

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

July 16, 2013

Status Verified

July 1, 2013

Enrollment Period

1.2 years

First QC Date

May 1, 2012

Last Update Submit

July 14, 2013

Conditions

Keywords

green teaagingatherosclerosishomocysteinecognitive impairment

Outcome Measures

Primary Outcomes (1)

  • Changes in the serum homocysteine levels

    Changes in the serum homocysteine levels before and after the intervention

    between baseline and 3 months after

Secondary Outcomes (3)

  • Changes in serum lipid levels

    between baseline and 3 months after

  • Changes in serum folic acid levels

    between baseline and 3 months after

  • Changes in mini mental state examination (MMSE) scores

    between baseline and 3 months after

Study Arms (1)

green tea powder

EXPERIMENTAL

Natural green tea powder

Dietary Supplement: green tea powder

Interventions

green tea powderDIETARY_SUPPLEMENT

Consuming 2 g/day of green tea powder in three times divided for 3 months

green tea powder

Eligibility Criteria

Age50 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obtained written informed consent before participation
  • Possible to consume green tea powder
  • Possessing cognitive dysfunction; MMSE score less than 30
  • Possible not to take any supplement possessing anti-oxidizing effect; i.e., vitamin A, C, E, β-carotene

You may not qualify if:

  • Possessing allergy to green tea
  • Possessing severe cardiac, respiratory, renal, or hepatic dysfunction
  • Possessing severe anemia
  • Diagnosed as inadequate to participate in the study by doctor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

White Cross Nursing Home

Higashimurayama, Tokyo, 189-0021, Japan

Location

MeSH Terms

Conditions

Cognitive DysfunctionAtherosclerosis

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Yamada, Hiroshi

    University of Shizuoka

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2012

First Posted

May 8, 2012

Study Start

May 1, 2012

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

July 16, 2013

Record last verified: 2013-07

Locations